Company / Income Tax per Share
Idexx Laboratories Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$3.24
FY2025
5-year range
$1.85 / $3.24
FY2021-FY2025
Trend
+21.4%
vs FY2024
Sector context
#13 of 154
Health Care
What the data says
Among 154 Health Care companies, Idexx Laboratories is in the bottom 8% for income tax per share. Income Tax per Share has increased for 5 consecutive years, from $0.93 in FY2020 to $3.24 in FY2025.
Based on SEC 10-K filings.
3.24 in FY2025 with a 5-year CAGR of +28.3%. Top quartile in the Health Care sector.
Increased from $2.61 to $3.24 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +14.9%
- 5-Year CAGR
- +28.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 154This company $3.24 Sector average $1.06
▼
+206.8% above sector average
Key checks
Key Insights
- Idexx Laboratories's income tax per share has grown for 5 consecutive years.
- In FY2025, income tax per share increased 21.4% year-over-year.
- Ranks #13 out of 154 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.24 | +21.4% |
| FY2024 | $2.67 | +2.5% |
| FY2023 | $2.61 | +21.9% |
| FY2022 | $2.14 | +15.8% |
| FY2021 | $1.85 | +97.7% |
| FY2020 | $0.93 | -14.8% |
| FY2019 | $1.10 | +18.4% |
| FY2018 | $0.93 | -26.3% |
| FY2017 | $1.26 | +27.9% |
| FY2016 | $0.98 | +31.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026